See also this year's filing and all EDGAR filings for this company.
PDF Report 0001674930_2019_Fulgent_Genetics_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.35469524804874253, 'aggregate_val': 58040000, 'exp_sum': 89942000, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 31902000, 'AssetsCurrent': 26138000, 'PropertyPlantAndEquipment': 6234000, 'remainder_Assets': 25668000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001674930, Fulgent Genetics Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 1,529,000 |
| 2 | AssetsCurrent | 39,543,000 |
| 3 | PropertyPlantAndEquipment | 6,446,000 |
| 4 | remainder_Assets | 6,386,000 |
| 5 | LongTermLiabilities | 14,000 |
| 6 | LiabilitiesCurrent | 2,738,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 10,697,000 |
| 10 | GeneralAndAdministrativeExpense | 5,538,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 4,652,000 |
| 15 | ResearchAndDevelopmentExpense | 5,534,000 |
| 16 | remainder_Expenses | 36,000 |
| 17 | remainder_Revenues | 21,351,000 |
| 18 | remainder_NetIncome | -501,000 |
| 19 | remainder_ComprehensiveNetIncome | 9,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 53,904,000 |
| 1 | Liabilities | 2,752,000 |
| 2 | Expenses | 26,457,000 |
| 3 | Revenues | 21,351,000 |
| 4 | StockholdersEquity | 51,152,000 |
| 5 | NetIncome | -5,607,000 |
| 6 | ComprehensiveNetIncome | -5,598,000 |
| 7 | BaseVar | 52,487,000 |
| 8 | EconomicCapitalRatio | 4.82 |
Edgar->Model Mapping
Feature Distribution
Change over Time
